Autolus Therapeutics
Price & Volume
Stats
See more52W Range | $1.10-$5 |
Market Cap | $356.6M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $29.9M |
Revenue Growth (YoY) | -11% |
Gross Profit (12 Mos) | -$154.5M |
Diluted EPS | -$0.87 |
News
See moreYahoo Finance • 7 days ago
Autolus Therapeutics to Present Clinical Data Update at the American College of Rheumatology (ACR) Convergence 2025
Yahoo Finance • last month
Autolus Therapeutics sees cash runway to launch, commercialization of obe-cel
Yahoo Finance • last month
Here are the major earnings before the open Tuesday
Yahoo Finance • 2 months ago
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks with ‘Strong Buy’ Ratings
About
CEO | Dr. Christian Martin Itin Ph.D. |
CFO | Mr. Robert F. Dolski |
Address | The Mediaworks, London, United Kingdom, W12 7FP |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 647 |
